Martin Thomsen Ernst

Medicine & Life Sciences

1. Denmark 100%
2. Diphosphonates 24%
3. Drug Utilization 24%
4. Cohort Studies 23%
5. Osteoporotic Fractures 22%
6. Prescriptions 22%
7. Severe Acute Respiratory Syndrome 19%
8. Alendronate 18%
9. Scotland 18%
10. Coronavirus 17%
11. SARS Virus 17%
12. Interrupted Time Series Analysis 17%
13. Osteoporosis 16%
14. Registries 16%
15. Bone Density 15%
16. England 15%
17. Propensity Score 15%
18. Tramadol 15%
19. Netherlands 14%
20. Hip Osteoarthritis 14%
21. Secondary Prevention 14%
22. Diclofenac 13%
23. Psychotropic Drugs 13%
24. Exercise 11%
25. Chronic Renal Insufficiency 10%
26. Dicloxacillin 9%
27. Comorbidity 9%
28. Microscopic Colitis 9%
29. Floxacillin 9%
30. Multimorbidity 9%
31. Hydroxyzine 9%
32. Tic Disorders 8%
33. Randomized Controlled Trials 8%
34. Therapeutics 8%
35. Dimethylnitrosamine 8%
36. Regression Analysis 8%
37. Valsartan 8%
38. Primary Prevention 7%
39. Child 7%
40. Tics 7%
41. Budesonide 7%
42. Confidence Intervals 7%
43. Spain 7%
44. Odds Ratio 7%
45. Exercise Therapy 7%
46. Atrial Fibrillation 6%
47. Hip Replacement Arthroplasties 6%
48. Hip 6%
49. Proton Pump Inhibitors 6%
50. Heart Valves 6%